140 related articles for article (PubMed ID: 28129717)
1. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?
Merki-Feld GS; Imthurn B; Dubey R; Sándor PS; Gantenbein AR
J Obstet Gynaecol; 2017 Apr; 37(3):338-341. PubMed ID: 28129717
[TBL] [Abstract][Full Text] [Related]
2. Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
Nappi RE; Merki-Feld GS; Terreno E; Pellegrinelli A; Viana M
J Headache Pain; 2013 Aug; 14(1):66. PubMed ID: 24456509
[TBL] [Abstract][Full Text] [Related]
3. Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days.
Merki-Feld GS; Imthurn B; Langner R; Seifert B; Gantenbein AR
J Headache Pain; 2015; 16():522. PubMed ID: 25933634
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis.
Warhurst S; Rofe CJ; Brew BJ; Bateson D; McGeechan K; Merki-Feld GS; Garrick R; Tomlinson SE
Cephalalgia; 2018 Apr; 38(4):754-764. PubMed ID: 28554244
[TBL] [Abstract][Full Text] [Related]
5. Progestin-only contraception compared with extended combined oral contraceptive in women with migraine without aura: a retrospective pilot study.
Morotti M; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():178-82. PubMed ID: 25461375
[TBL] [Abstract][Full Text] [Related]
6. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH).
Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Gantenbein AR; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Paemeleire K; Sandset PM; Terwindt GM; Vetvik KG; Martelletti P;
J Headache Pain; 2018 Aug; 19(1):76. PubMed ID: 30171365
[TBL] [Abstract][Full Text] [Related]
7. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
8. Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary study.
Merki-Feld GS; Imthurn B; Langner R; Sándor PS; Gantenbein AR
Cephalalgia; 2013 Apr; 33(5):340-6. PubMed ID: 23297380
[TBL] [Abstract][Full Text] [Related]
9. Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial.
Merki-Feld GS; Imthurn B; Gantenbein AR; Sandor P
Eur J Contracept Reprod Health Care; 2019 Jun; 24(3):175-181. PubMed ID: 31094588
[No Abstract] [Full Text] [Related]
10. Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study.
Nappi RE; Sances G; Allais G; Terreno E; Benedetto C; Vaccaro V; Polatti F; Facchinetti F
Contraception; 2011 Mar; 83(3):223-8. PubMed ID: 21310283
[TBL] [Abstract][Full Text] [Related]
11. Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
Máximo MM; Silva PS; Vieira CS; Gonçalvez TM; Rosa-E-Silva JC; Candido-Dos-Reis FJ; Nogueira AA; Poli-Neto OB
Fertil Steril; 2015 Nov; 104(5):1182-9. PubMed ID: 26341277
[TBL] [Abstract][Full Text] [Related]
12. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
Merki-Feld GS; Epple G; Caveng N; Imthurn B; Seifert B; Sandor P; Gantenbein AR
J Headache Pain; 2017 Aug; 18(1):91. PubMed ID: 28842849
[TBL] [Abstract][Full Text] [Related]
13. Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine - temporal relation to bleeding and hormone withdrawal: a prospective diary-based study.
Merki-Feld GS; Caveng N; Speiermann G; MacGregor EA
J Headache Pain; 2020 Jun; 21(1):81. PubMed ID: 32580694
[TBL] [Abstract][Full Text] [Related]
14. Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study.
De Icco R; Cucinella L; De Paoli I; Martella S; Sances G; Bitetto V; Sandrini G; Nappi G; Tassorelli C; Nappi RE
J Headache Pain; 2016 Dec; 17(1):70. PubMed ID: 27488685
[TBL] [Abstract][Full Text] [Related]
15. Safety of hormonal contraceptives among women with migraine: A systematic review.
Tepper NK; Whiteman MK; Zapata LB; Marchbanks PA; Curtis KM
Contraception; 2016 Dec; 94(6):630-640. PubMed ID: 27153744
[TBL] [Abstract][Full Text] [Related]
16. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1995 Dec; 346(8990):1582-8. PubMed ID: 7500749
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraception, thrombosis and age.
Lidegaard Ø
Expert Opin Drug Saf; 2014 Oct; 13(10):1353-60. PubMed ID: 25227335
[TBL] [Abstract][Full Text] [Related]
18. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
Vree ML; Schmidt J
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception.
Brache V; Cochon L; Duijkers IJ; Levy DP; Kapp N; Monteil C; Abitbol JL; Klipping C
Hum Reprod; 2015 Dec; 30(12):2785-93. PubMed ID: 26405263
[TBL] [Abstract][Full Text] [Related]
20. Treating migraine with contraceptives.
Allais G; Chiarle G; Sinigaglia S; Airola G; Schiapparelli P; Bergandi F; Benedetto C
Neurol Sci; 2017 May; 38(Suppl 1):85-89. PubMed ID: 28527064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
